Business Description
Arzneiwerk AG VIDA
NAICS : 423450
SIC : 5122
ISIN : DE000A289B07
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | -0.41 | |||||
Debt-to-Equity | -2.34 | |||||
Debt-to-EBITDA | -23 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -3.38 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25.4 | |||||
3-Year EPS without NRI Growth Rate | -132.9 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.2 | |||||
9-Day RSI | 50 | |||||
14-Day RSI | 47.82 | |||||
6-1 Month Momentum % | -23.5 | |||||
12-1 Month Momentum % | -42.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.63 | |||||
Quick Ratio | 0.26 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 8343.56 | |||||
Days Sales Outstanding | 141.69 | |||||
Days Payable | 2030.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 | |||||
Shareholder Yield % | 41.84 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 87.48 | |||||
Operating Margin % | -15.81 | |||||
Net Margin % | -58.7 | |||||
FCF Margin % | 0.87 | |||||
ROA % | -11.36 | |||||
ROIC % | -2.38 | |||||
ROC (Joel Greenblatt) % | -22.25 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 5.75 | |||||
PS Ratio | 2.02 | |||||
Price-to-Free-Cash-Flow | 223.33 | |||||
Price-to-Operating-Cash-Flow | 47.86 | |||||
EV-to-EBIT | -15.99 | |||||
EV-to-EBITDA | -29.13 | |||||
EV-to-Revenue | 7.11 | |||||
EV-to-FCF | 817.17 | |||||
Earnings Yield (Greenblatt) % | -6.25 | |||||
FCF Yield % | 0.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Arzneiwerk AG VIDA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2.068 | ||
EPS (TTM) (€) | -0.195 | ||
Beta | 1.92 | ||
Volatility % | 34.95 | ||
14-Day RSI | 47.82 | ||
14-Day ATR (€) | 0.060077 | ||
20-Day SMA (€) | 0.671 | ||
12-1 Month Momentum % | -42.48 | ||
52-Week Range (€) | 0.595 - 1.42 | ||
Shares Outstanding (Mil) | 6.23 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arzneiwerk AG VIDA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arzneiwerk AG VIDA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Arzneiwerk AG VIDA Frequently Asked Questions
What is Arzneiwerk AG VIDA(STU:TLIK)'s stock price today?
When is next earnings date of Arzneiwerk AG VIDA(STU:TLIK)?
Does Arzneiwerk AG VIDA(STU:TLIK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |